Innova Therapeutics

Innova Therapeutics is a biotechnology company based in Charleston, South Carolina, dedicated to developing a monoclonal antibody (mAb) platform that targets proteins highly expressed in various solid cancers and associated with patient prognosis. Innova's platform technology initially focuses on cancers including pediatric osteosarcoma, sarcoma, breast cancer, and pancreatic cancer. The opportunities for this anticancer therapy as a single agent and in combination with other chemotherapeutic drugs will expand to other solid tumors.